English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduValue in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the publication of a new ISPOR Good Practices Report on patient-preference studies and introduces the ISPOR Roadmap for Patient Preferences in Decision Making,
Tag: patient preferences
Coming of Age: Emerging Health Preference Research Based on Established Scientific Standards
Value in Health, the official journal of ISPOR, announced today the publication of a series of articles focused on recent developments in the field of health preference research.
Incorporating Patients’ Perspectives in the Medical Device Regulatory Process
Value in Health announced today the publication of an article highlighting US Food and Drug Administration (FDA) guidance and lessons learned regarding the use of patient preference information for FDA decision making about medical devices.
Nurse Practitioner Clinical Settings Key to Delivery of Patient-Centered Care
It’s long been understood that care that respects and integrates the wants, needs, and preferences of patients results in higher ratings of satisfaction and improved health outcomes. Yet, several barriers still often impede the delivery of patient-centered care. A new study from the University of Pennsylvania School of Nursing (Penn Nursing) shows that organizational supports for nurse practitioners (NPs) can enhance their ability to deliver patient-centered care.
KIDNEY HEALTH INITIATIVE LAUNCHES PROJECT TO MEASURE PATIENT PREFERENCES FOR NOVEL KIDNEY DEVICES
The US Food and Drug Administration (FDA) has awarded a contract to the Kidney Health Initiative (KHI) to study patient preferences for innovative renal replacement therapy (RRT) devices. The three-year project, “Building Capacity to Incorporate Patient Preferences into the Development of Innovative Alternatives to Renal Replacement Therapy” will capture patient preference and risk tolerance data from people with kidney failure to drive innovations in RRT.